Ongoing Guidelines

Guidelines in Pipeline

An EAN guideline goes through a rigorus development process before it is published on the European Journal of Neurology (EJoN)

Below is the list of ongoing guidelines in different stages of development. (as of November 2023)

  • EAN guideline on the management of amyotrophic lateral sclerosis in collaboration with ERN Euro-NMD
    Guideline Task Force Chair: P. van Damme
  •  
  • Consensus guidelines  for the management of  autoimmune encephalitis
    Guideline Task Force Co-Chairs: M. Titulaer, L. Massacesi
     
  • EAN-ESCMID Guideline investigation and management of adults with encephalitis
    Guideline Task Force Chair: T. Whitfield
     
  • Management of neurogenic lower urinary tract and sexual dysfunction for the practicing neurologist
    Guideline Task Force Chair: J. Panicker
     
  • EAN guidelines for a precise diagnosis of HyperCKemia
    Guideline Task Force Chair: T. Kyriakides
  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis (update)
    Guideline Task Force Chair: X. Montalban/ M. P. Amato
     
  • European guidelines on the management of Restless Legs Syndrome
    Guideline Task Force Chair: A. Stefani
     
  • Diagnosis and treatment of Metachromatic Leukodystrophy: guideline within ERN-RND 
    Guideline Task Force Chair: S. Gröschel 
  • EAN - EPiCare clinical practice guidelines in the field of rare and complex epilepsies
    1.    Status Epilepticus (SE)
    2.    Dravet Syndrome (DS)
    3.    Infantile Spasms (IS)
    4.    Lennox Gastaut Syndrome (LGS)
    Guideline Task Force Chair: E. Trinka
     
  • EAN/ERN-RND/MDS-ES Guidelines for the symptomatic treatment of atypical Parkinsonian Syndromes (MSA, PSP, CBD)
    Guideline Task Force Chair: A. Fanciulli
     
  • EAN-MDS-ES guideline on Parkinson's disease - Part II: Pharmacological management of motor symptoms
    Guideline Task Force Chair: E. Moro
     
  • EAN-ILAE-EpiCARE joint guidelines for presurgical evaluation and surgical treatment of patients with complex and drug resistant epilepsies
    Guideline Task Force Co-chairs: E. Trinka, P. Ryvlin
     
  • EAN/EHF Guidelines on Spontaneous Intracranial Hypotension and Orthostatic Headache
    Guideline Task Force Chair: C. Schankin
     
  • EAN-ECTRIMS Guideline on diagnosis and management of NMOSD: an update/European Guidelines for the treatment of NMOSD
    Guideline Task Force Co-chairs: B. Willekens, R. Marignier
     
  •  
  • EAN guideline on “Pharmacological and interventional treatment of migraine“ (update)
    Guideline Task Force Chair: P. Irimia, D. Mitsikostas

     
  • ESO-EAN Post-stroke cognitive rehabilitation guideline
    Guideline Task Force Co-chairs: T. Quinn, H. Christensen
     
  • EAN Post-stroke rehabilitation guideline
    Guideline Task Force Co-Chairs: S. Filipovic, D. Muresanu
     
  • EAN/PNS Amyloid (ATTRv) Neuropathy guideline
    Guideline Task Force Co-chairs: T. Coelho, M. Polydefkis
     
  • EAN/PNS guideline on management of multifocal motor neuropathy
    Guideline Task Force Chair: S. Goedee
     
  • EAN Guideline on Narcolepsy
    Guideline Task Force Chair: C. Bassetti
About Guidelines
Guideline Reference Center

Questions or Concerns?

Please contact EAN Scientific Department at scientific(at)ean.org